Primary-Mode-Of-Action Rule For Combo Products Is Similar To Earlier Draft

FDA's "primary-mode-of-action" 1final rule for combination products largely mirrors the language of last year's proposed version, although the agency adds clarification on various issues raised by stakeholders

More from Archive

More from Medtech Insight